Financhill
Back

Catalyst Pharmaceuticals Stock Price Chart

My #1 Coin is...

All the details are on the next page.
Sell
48

CPRX
Catalyst Pharmaceuticals

Last Price:
15.22
Seasonality Move:
8.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

Catalyst Pharmaceuticals Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 15.5 Sell
20-day SMA: 15.83 Sell
50-day SMA: 15.17 Buy
200-day SMA: 14.09 Buy
8-day EMA: 15.58 Sell
20-day EMA: 15.67 Sell
50-day EMA: 15.41 Sell
200-day EMA: 14.52 Buy

Catalyst Pharmaceuticals Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 44.9 Sell
Chaikin Money Flow: -550362 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.46 - 16.38) Sell
Bollinger Bands (100): (13.89 - 16.13) Buy

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Catalyst Pharmaceuticals Stock

Is Catalyst Pharmaceuticals Stock a Buy?

CPRX Technical Analysis vs Fundamental Analysis

Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy or a Sell?

Catalyst Pharmaceuticals Stock Info

Market Cap:
1.79B
Price in USD:
15.22
Share Volume:
858.56K

Catalyst Pharmaceuticals 52-Week Range

52-Week High:
18.22
52-Week Low:
11.09
Sell
48
Catalyst Pharmaceuticals (CPRX) is a Sell

Catalyst Pharmaceuticals Share Price Forecast

Is Catalyst Pharmaceuticals Stock a Buy?

Fundamental Analysis of Catalyst Pharmaceuticals

Is Catalyst Pharmaceuticals a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Technical Analysis of Catalyst Pharmaceuticals

Should I short Catalyst Pharmaceuticals stock?

* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.